CANbridge Pharmaceuticals Inc. (HKG:1228)

Hong Kong · Delayed Price · Currency is HKD

2.005

+0.095 (4.97%)

Sep 18, 2026, 4:08 PM HKT

CANbridge Pharmaceuticals Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	55.68	49.98	85.1	102.87	78.97	31.16
Revenue Growth	11.39%	-41.27%	-17.27%	30.26%	153.43%	158.98%
Gross Profit	40.56	37.33	54.3	64.16	48.89	18.78
Operating Income	-98.14	-91.93	-340.52	-366.55	-457.97	-655.15
Net Income	-81.51	14.82	-442.62	-378.84	-483.48	-1,077
Earnings Per Share	-0.16	0.03	-1.04	-0.89	-1.14	-11.43
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Chinese Mainland	55.62	49.92	40.97	55.87	31.49	7.35
Other Countries/Regions	-	0.06	44.13	47	47.48	23.81
Total	55.68	49.98	85.1	102.87	78.97	31.16

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	88.1	66.63	10.5	137.49	463.11	745.82
Total Debt	28.81	16.08	135.78	141.93	155.28	52.1
Net Cash (Debt)	59.29	50.54	-125.28	-4.44	307.83	693.71
Net Cash Growth	17.31%	-	-	-	-55.63%	-
Net Cash Per Share	0.11	0.11	-0.29	-0.01	0.73	7.36

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-	-38.21	-122.4	-278.23	-280.98	-587.07
Capital Expenditures	-	-0.01	-0.11	-5.14	-15.2	-5.09
Free Cash Flow	-	-38.22	-122.5	-283.38	-296.18	-592.16
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	72.86%	74.67%	63.81%	62.37%	61.91%	60.26%
Operating Margin	-176.27%	-183.92%	-400.12%	-356.32%	-579.91%	-2102.46%
Pretax Margin	-146.41%	29.65%	-520.10%	-368.26%	-612.21%	-3456.26%
Profit Margin	-146.41%	29.65%	-520.10%	-368.26%	-612.21%	-3456.26%
FCF Margin	-	-76.46%	-143.94%	-275.47%	-375.04%	-1900.31%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	79.35	-	-	-	-
PS Ratio	18.64	23.52	0.62	3.71	11.64	98.48